2.13. Analysis.

Comparison 2 Interleukin‐2 receptor antagonist versus corticosteroid induction (type of IL2RA), Outcome 13 Diabetes mellitus.

Comparison 2 Interleukin‐2 receptor antagonist versus corticosteroid induction (type of IL2RA), Outcome 13 Diabetes mellitus.